Literature DB >> 2451759

Presentation and immunogenicity of the hepatitis B surface antigen and a poliovirus neutralization antigen on mixed empty envelope particles.

F Delpeyroux1, N Peillon, B Blondel, R Crainic, R E Streeck.   

Abstract

Insertion of a synthetic DNA fragment encoding a poliovirus neutralization epitope into the S gene encoding the major envelope protein of hepatitis B virus has yielded hybrid (HBsPolioAg) particles closely resembling authentic 22-nm antigen (HBsAg) particles by expression of the modified gene in mammalian cells. In mice, these hybrid particles induce neutralizing antibodies against poliovirus but only weak immune response to HBsAg (F. Delpeyroux, N. Chenciner, A. Lim, Y. Malpièce, B. Blondel, R. Crainic, S. Van der Werf, and R. E. Streeck, Science 233:472-474, 1986). By cotransfection with different plasmids carrying either modified or unmodified S genes, we have now obtained mixed particles presenting both HBsAg and HBsPolioAg. When such particles were inoculated into rabbits, antibodies to both poliovirus and to HBsAg were induced. Moreover, the titers of neutralizing antibodies to poliovirus induced by HBsPolioAg were much higher than those previously obtained in mice. The design of multivalent particles carrying various peptide sequences or presenting several heterologous epitopes may therefore be possible.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451759      PMCID: PMC253244     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.

Authors:  B Blondel; R Crainic; O Fichot; G Dufraisse; A Candrea; D Diamond; M Girard; F Horaud
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

2.  Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3.

Authors:  M Ferguson; D M Evans; D I Magrath; P D Minor; J W Almond; G C Schild
Journal:  Virology       Date:  1985-06       Impact factor: 3.616

Review 3.  Identification and characterization of a continuous neutralization epitope (C3) present on type 1 poliovirus.

Authors:  F Horaud; R Crainic; S Van der Werf; B Blondel; C Wichowski; O Akacem; P Bruneau; P Couillin; O Siffert; M Girard
Journal:  Prog Med Virol       Date:  1987

4.  A new dominant hybrid selective marker for higher eukaryotic cells.

Authors:  F Colbère-Garapin; F Horodniceanu; P Kourilsky; A C Garapin
Journal:  J Mol Biol       Date:  1981-07-25       Impact factor: 5.469

5.  Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides.

Authors:  E A Emini; B A Jameson; E Wimmer
Journal:  Nature       Date:  1983 Aug 25-31       Impact factor: 49.962

6.  Structural relationships between minor and major proteins of hepatitis B surface antigen.

Authors:  W Stibbe; W H Gerlich
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

7.  Intracellular assembly and packaging of hepatitis B surface antigen particles occur in the endoplasmic reticulum.

Authors:  E J Patzer; G R Nakamura; C C Simonsen; A D Levinson; R Brands
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

Review 8.  The hepatitis B virus.

Authors:  P Tiollais; C Pourcel; A Dejean
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

9.  Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA.

Authors:  M F Dubois; C Pourcel; S Rousset; C Chany; P Tiollais
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

10.  Expression of the hepatitis B virus surface antigen gene in cell culture by using a simian virus 40 vector.

Authors:  A M Moriarty; B H Hoyer; J W Shih; J L Gerin; D H Hamer
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

View more
  11 in total

1.  Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins.

Authors:  R Prange; A Clemen; R E Streeck
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Mutational analysis of hepatitis B surface antigen particle assembly and secretion.

Authors:  V Bruss; D Ganem
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles.

Authors:  F Delpeyroux; E Van Wezel; B Blondel; R Crainic
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

4.  Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes.

Authors:  H J Netter; T B Macnaughton; W P Woo; R Tindle; E J Gowans
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

5.  Proposition of a three-dimensional representation of the constitutive protein of the hepatitis B surface antigen particles.

Authors:  N Sonveaux; J M Ruysschaert; R Brasseur
Journal:  J Protein Chem       Date:  1995-08

6.  Concomitant cellular expression of heat shock regulated genes of hepatitis B virus surface antigen and of human growth hormone by a NIH-3T3 cell line.

Authors:  P L'Hote; S Alouani; J B Marq; F Montandon; M Chessebeuf-Padieu; M Dreano
Journal:  Cell Biol Toxicol       Date:  1993 Oct-Dec       Impact factor: 6.691

7.  Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1.

Authors:  C Leclerc; E Deriaud; V Mimic; S van der Werf
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  Mosaic RNA phage VLPs carrying domain III of the West Nile virus E protein.

Authors:  Indulis Cielens; Ludmila Jackevica; Arnis Strods; Andris Kazaks; Velta Ose; Janis Bogans; Paul Pumpens; Regina Renhofa
Journal:  Mol Biotechnol       Date:  2014-05       Impact factor: 2.860

9.  DNA-Loaded Cationic Liposomes Efficiently Function as a Vaccine against Malarial Proteins.

Authors:  Wesley L Fotoran; Rachele Santangelo; Beatriz N M de Miranda; Darrell J Irvine; Gerhard Wunderlich
Journal:  Mol Ther Methods Clin Dev       Date:  2017-08-23       Impact factor: 6.698

Review 10.  Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.

Authors:  Joan Kha-Tu Ho; Beena Jeevan-Raj; Hans-Jürgen Netter
Journal:  Viruses       Date:  2020-01-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.